Xtant Medical and Dilon Technologies Announce Exclusive U.S. Distribution Agreement for Dilon's HEMOBLAST® Bellows Product

Stock Information for Xtant Medical Holdings Inc.

Loading

Please wait while we load your information from QuoteMedia.

More Recent News About Xtant Medical Holdings Inc.

Xtant Medical Reports First Quarter 2026 Financial Results
Xtant Medical to Announce First Quarter 2026 Financial Results on May 13, 2026
Xtant Medical Expands Trivium(TM) Portfolio with the Commercial Launch of Trivium(TM) Shaped
Xtant Medical and Montana Governor's Office of Community Service Announce Support for "Threshold of Life" Memorial
Xtant Medical Reports Fourth Quarter and Full-Year 2025 Financial Results
Xtant Medical to Announce Fourth Quarter and Full Year 2025 Financial Results on March 31, 2026
Xtant Medical Finalizes Companion Spine Transactions
Xtant Medical to Participate in the Canaccord Genuity 2026 Musculoskeletal Conference

Market data content copyright © QuoteMedia. Data delayed at least 15 minutes unless otherwise indicated (view Delay Times for all exchanges). Filings and Fundamentals by Morningstar. Insiders by Morningstar (USA) and SEDI (CDN). Analyst ratings by Zacks. Terms of Use.